RecallDepth
Class II Ongoing

0.9% Sodium Chloride Injection, USP, Each 100 mL contains: SODIUM CHLORIDE, USP - 900 mg, WATER FOR INJECTION, USP - qs, 1000mL Bag, 12 PK, Rx Only, Fresenius Medical Care North America, Waltham, MA 02451, NDC 49230-300-10

This recall is currently active, issued October 26, 2022. It was issued by Fresenius Medical Care Holdings, Inc..

Company
Fresenius Medical Care Holdings, Inc.
Recall Initiated
October 11, 2022
Posted
October 26, 2022
Recall Number
D-0015-2023
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
16,006 cases of twelve bags each
Firm Location
Waltham, MA, United States
Official Source
View on FDA website ↗

Reason for Recall

Lack of Assurance of Sterility: Leakage of 0.9% Sodium Chloride for Injection, 1L, 12pk Saline Solution.

Distribution

Nationwide in the USA

Lot / Code Info

Lot # 22EU05043, EXP 5/21/2023; 22HU05018, EXP 6/9/2023; 22HU05019, EXP 6/10/2023; 22HU05025, 22HU05026, EXP 6/12/2023; 22HU05049, EXP 6/22/2023; 22HU05053, EXP 6/24/2023; 22HU05054, 22HU05055, EXP 6/25/2023; 22HU06027, EXP 6/11/2023; 22HU06049, EXP 6/23/2023; 22HU06055, EXP 6/24/2023; 22HU06056, EXP 6/25/2023; 22JU05008, EXP 7/4/2023; 22KU06036, EXP 8/19/2023; 22JU06023, EXP 7/8/2023

More recalls by Fresenius Medical Care Holdings, Inc.

View all recalls by this company →

Other recent Class II Drug recalls